Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ · Healthcare
Madrigal Pharmaceuticals, Inc. Net Income 2012–2025
Madrigal Pharmaceuticals, Inc. annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Madrigal Pharmaceuticals, Inc. net income for the quarter ending March 31, 2026 was -94.4 M, a 28.88% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. net income for the twelve months ending March 31, 2026 was -324.1 M, a 35.85% decrease year-over-year.
- Madrigal Pharmaceuticals, Inc. annual net income for 2025 was -288.3 M, a 38.12% decrease from 2024.
- Madrigal Pharmaceuticals, Inc. annual net income for 2024 was -465.9 M, a 24.69% increase from 2023.
- Madrigal Pharmaceuticals, Inc. annual net income for 2023 was -373.6 M, a 26.50% increase from 2022.
- Madrigal Pharmaceuticals, Inc. annual net income for 2022 was -295.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Madrigal Pharmaceuticals, Inc. Net Income — FAQ
Madrigal Pharmaceuticals, Inc. (MDGL) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Madrigal Pharmaceuticals, Inc.'s net income?
Madrigal Pharmaceuticals, Inc. (MDGL) reported net income of -$288M for fiscal 2025.
Where can I see MDGL's net income history?
The chart and table above show Madrigal Pharmaceuticals, Inc.'s net income by year and by quarter, including the growth rate.